D-1863-2019 Class II Terminated
FDA drug recall D-1863-2019 was initiated by West-Ward Columbus Inc on Sep 9, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specificattion The recall status is terminated (terminated Jun 15, 2022). Affected quantity: 32,347 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 25, 2019
- Initiation Date
- Sep 9, 2019
- Termination Date
- Jun 15, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 32,347 bottles
Product description
Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59
Reason for recall
Failed Impurities/Degradation Specificattion
Distribution pattern
Nationwide USA and Puerto Rico
Code information
Lot, expiry: Lots AA3957A, AA3958A, exp May 2020; Lot AA5164A, exp Sep 2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1863-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026